id	sid	tid	token	lemma	pos
dpc-1517	1	1	dermatology	dermatology	NOUN
dpc-1517	1	2	:	:	PUNCT
dpc-1517	1	3	practical	practical	ADJ
dpc-1517	1	4	and	and	CCONJ
dpc-1517	1	5	conceptual	conceptual	ADJ
dpc-1517	1	6	dermatology	dermatology	NOUN
dpc-1517	1	7	practical	practical	ADJ
dpc-1517	1	8	&	&	CCONJ
dpc-1517	1	9	conceptual	conceptual	ADJ
dpc-1517	1	10	letter	letter	NOUN
dpc-1517	2	1	|	|	ADV
dpc-1517	2	2	dermatol	dermatol	ADJ
dpc-1517	2	3	pract	pract	NOUN
dpc-1517	2	4	concept	concept	NOUN
dpc-1517	2	5	.	.	PUNCT
dpc-1517	3	1	2021.11(3	2021.11(3	NUM
dpc-1517	3	2	):	):	PUNCT
dpc-1517	3	3	e2021043	e2021043	NOUN
dpc-1517	3	4	1	1	NUM
dpc-1517	3	5	bevacizumab	bevacizumab	ADV
dpc-1517	3	6	-	-	PUNCT
dpc-1517	3	7	induced	induce	VERB
dpc-1517	3	8	geographic	geographic	ADJ
dpc-1517	3	9	tongue	tongue	NOUN
dpc-1517	3	10	marta	marta	PROPN
dpc-1517	3	11	martinez	martinez	PROPN
dpc-1517	3	12	-	-	PUNCT
dpc-1517	3	13	garcia	garcia	PROPN
dpc-1517	3	14	,	,	PUNCT
dpc-1517	3	15	jorge	jorge	VERB
dpc-1517	3	16	roman	roman	PROPN
dpc-1517	3	17	-	-	PUNCT
dpc-1517	3	18	sainz	sainz	PROPN
dpc-1517	3	19	,	,	PUNCT
dpc-1517	3	20	nicolás	nicolás	NOUN
dpc-1517	3	21	silvestre	silvestre	PROPN
dpc-1517	3	22	-	-	PUNCT
dpc-1517	3	23	torner	torner	NOUN
dpc-1517	3	24	,	,	PUNCT
dpc-1517	3	25	sergio	sergio	PROPN
dpc-1517	3	26	tabbara	tabbara	PROPN
dpc-1517	3	27	carrascosa	carrascosa	PROPN
dpc-1517	3	28	dermatology	dermatology	PROPN
dpc-1517	3	29	service	service	PROPN
dpc-1517	3	30	.	.	PUNCT
dpc-1517	4	1	severo	severo	PROPN
dpc-1517	4	2	ochoa	ochoa	PROPN
dpc-1517	4	3	university	university	PROPN
dpc-1517	4	4	hospital	hospital	NOUN
dpc-1517	4	5	,	,	PUNCT
dpc-1517	4	6	leganés	leganés	PROPN
dpc-1517	4	7	,	,	PUNCT
dpc-1517	4	8	madrid	madrid	PROPN
dpc-1517	4	9	key	key	PROPN
dpc-1517	4	10	words	word	NOUN
dpc-1517	4	11	:	:	PUNCT
dpc-1517	4	12	bevacizumab	bevacizumab	PROPN
dpc-1517	4	13	,	,	PUNCT
dpc-1517	4	14	geographic	geographic	ADJ
dpc-1517	4	15	tongue	tongue	NOUN
dpc-1517	4	16	,	,	PUNCT
dpc-1517	4	17	self	self	NOUN
dpc-1517	4	18	-	-	PUNCT
dpc-1517	4	19	solving	solving	NOUN
dpc-1517	4	20	,	,	PUNCT
dpc-1517	4	21	infiltrating	infiltrate	VERB
dpc-1517	4	22	ductal	ductal	ADJ
dpc-1517	4	23	carcinoma	carcinoma	NOUN
dpc-1517	4	24	,	,	PUNCT
dpc-1517	4	25	vascular	vascular	ADJ
dpc-1517	4	26	endothelial	endothelial	ADJ
dpc-1517	4	27	growth	growth	NOUN
dpc-1517	4	28	factor	factor	NOUN
dpc-1517	4	29	protein	protein	NOUN
dpc-1517	4	30	citation	citation	NOUN
dpc-1517	4	31	:	:	PUNCT
dpc-1517	5	1	martinez	martinez	PROPN
dpc-1517	5	2	-	-	PUNCT
dpc-1517	5	3	garcia	garcia	PROPN
dpc-1517	5	4	m	m	PROPN
dpc-1517	5	5	,	,	PUNCT
dpc-1517	5	6	roman	roman	PROPN
dpc-1517	5	7	-	-	PUNCT
dpc-1517	5	8	sainz	sainz	PROPN
dpc-1517	5	9	j	j	PROPN
dpc-1517	5	10	,	,	PUNCT
dpc-1517	5	11	silvestre	silvestre	NOUN
dpc-1517	5	12	-	-	PUNCT
dpc-1517	5	13	torner	torner	NOUN
dpc-1517	5	14	n	n	CCONJ
dpc-1517	5	15	,	,	PUNCT
dpc-1517	5	16	tabbara	tabbara	PROPN
dpc-1517	5	17	carrascosa	carrascosa	PROPN
dpc-1517	5	18	s.	s.	PROPN
dpc-1517	5	19	bevacizumab	bevacizumab	PROPN
dpc-1517	5	20	-	-	PUNCT
dpc-1517	5	21	induced	induce	VERB
dpc-1517	5	22	geographic	geographic	ADJ
dpc-1517	5	23	tongue	tongue	NOUN
dpc-1517	5	24	.	.	PUNCT
dpc-1517	6	1	dermatol	dermatol	NOUN
dpc-1517	6	2	pract	pract	PROPN
dpc-1517	6	3	concept	concept	NOUN
dpc-1517	6	4	.	.	PUNCT
dpc-1517	7	1	2021.11(3	2021.11(3	NUM
dpc-1517	7	2	):	):	PUNCT
dpc-1517	8	1	e2021043	e2021043	NOUN
dpc-1517	8	2	.	.	PUNCT
dpc-1517	9	1	doi	doi	PROPN
dpc-1517	9	2	:	:	PUNCT
dpc-1517	9	3	https://doi.org/10.5826/dpc.1103a43	https://doi.org/10.5826/dpc.1103a43	PROPN
dpc-1517	9	4	accepted	accept	VERB
dpc-1517	9	5	:	:	PUNCT
dpc-1517	9	6	november	november	PROPN
dpc-1517	9	7	23	23	NUM
dpc-1517	9	8	,	,	PUNCT
dpc-1517	9	9	2020	2020	NUM
dpc-1517	9	10	;	;	PUNCT
dpc-1517	9	11	published	publish	VERB
dpc-1517	9	12	:	:	PUNCT
dpc-1517	9	13	july	july	PROPN
dpc-1517	9	14	8	8	NUM
dpc-1517	9	15	,	,	PUNCT
dpc-1517	9	16	2021	2021	NUM
dpc-1517	9	17	copyright	copyright	NOUN
dpc-1517	9	18	:	:	PUNCT
dpc-1517	10	1	©	©	PROPN
dpc-1517	10	2	2021	2021	NUM
dpc-1517	10	3	martinez	martinez	PROPN
dpc-1517	10	4	-	-	PUNCT
dpc-1517	10	5	garcia	garcia	PROPN
dpc-1517	10	6	et	et	PROPN
dpc-1517	10	7	al	al	PROPN
dpc-1517	10	8	.	.	PUNCT
dpc-1517	11	1	this	this	PRON
dpc-1517	11	2	is	be	AUX
dpc-1517	11	3	an	an	DET
dpc-1517	11	4	open	open	ADJ
dpc-1517	11	5	-	-	PUNCT
dpc-1517	11	6	access	access	NOUN
dpc-1517	11	7	article	article	NOUN
dpc-1517	11	8	distributed	distribute	VERB
dpc-1517	11	9	under	under	ADP
dpc-1517	11	10	the	the	DET
dpc-1517	11	11	terms	term	NOUN
dpc-1517	11	12	of	of	ADP
dpc-1517	11	13	the	the	DET
dpc-1517	11	14	creative	creative	ADJ
dpc-1517	11	15	commons	common	NOUN
dpc-1517	11	16	attribution	attribution	NOUN
dpc-1517	11	17	license	license	NOUN
dpc-1517	11	18	by	by	ADP
dpc-1517	11	19	-	-	PUNCT
dpc-1517	11	20	nc-4.0	nc-4.0	NOUN
dpc-1517	11	21	,	,	PUNCT
dpc-1517	11	22	which	which	PRON
dpc-1517	11	23	permits	permit	VERB
dpc-1517	11	24	unrestricted	unrestricted	ADJ
dpc-1517	11	25	noncommercial	noncommercial	ADJ
dpc-1517	11	26	use	use	NOUN
dpc-1517	11	27	,	,	PUNCT
dpc-1517	11	28	distribution	distribution	NOUN
dpc-1517	11	29	,	,	PUNCT
dpc-1517	11	30	and	and	CCONJ
dpc-1517	11	31	reproduction	reproduction	NOUN
dpc-1517	11	32	in	in	ADP
dpc-1517	11	33	any	any	DET
dpc-1517	11	34	medium	medium	NOUN
dpc-1517	11	35	,	,	PUNCT
dpc-1517	11	36	provided	provide	VERB
dpc-1517	11	37	the	the	DET
dpc-1517	11	38	original	original	ADJ
dpc-1517	11	39	authors	author	NOUN
dpc-1517	11	40	and	and	CCONJ
dpc-1517	11	41	source	source	NOUN
dpc-1517	11	42	are	be	AUX
dpc-1517	11	43	credited	credit	VERB
dpc-1517	11	44	.	.	PUNCT
dpc-1517	12	1	funding	funding	NOUN
dpc-1517	12	2	:	:	PUNCT
dpc-1517	12	3	none	none	NOUN
dpc-1517	12	4	.	.	PUNCT
dpc-1517	13	1	competing	compete	VERB
dpc-1517	13	2	interests	interest	NOUN
dpc-1517	13	3	:	:	PUNCT
dpc-1517	13	4	the	the	DET
dpc-1517	13	5	authors	author	NOUN
dpc-1517	13	6	have	have	VERB
dpc-1517	13	7	no	no	DET
dpc-1517	13	8	conflicts	conflict	NOUN
dpc-1517	13	9	of	of	ADP
dpc-1517	13	10	interest	interest	NOUN
dpc-1517	13	11	to	to	PART
dpc-1517	13	12	disclose	disclose	VERB
dpc-1517	13	13	.	.	PUNCT
dpc-1517	14	1	authorship	authorship	NOUN
dpc-1517	14	2	:	:	PUNCT
dpc-1517	14	3	all	all	DET
dpc-1517	14	4	authors	author	NOUN
dpc-1517	14	5	have	have	AUX
dpc-1517	14	6	contributed	contribute	VERB
dpc-1517	14	7	significantly	significantly	ADV
dpc-1517	14	8	to	to	ADP
dpc-1517	14	9	this	this	DET
dpc-1517	14	10	publication	publication	NOUN
dpc-1517	14	11	.	.	PUNCT
dpc-1517	15	1	corresponding	correspond	VERB
dpc-1517	15	2	author	author	NOUN
dpc-1517	15	3	:	:	PUNCT
dpc-1517	15	4	marta	marta	PROPN
dpc-1517	15	5	martínez	martínez	PROPN
dpc-1517	15	6	garcía	garcía	PROPN
dpc-1517	15	7	,	,	PUNCT
dpc-1517	15	8	dermatology	dermatology	NOUN
dpc-1517	15	9	service	service	NOUN
dpc-1517	15	10	.	.	PUNCT
dpc-1517	16	1	severo	severo	PROPN
dpc-1517	16	2	ochoa	ochoa	PROPN
dpc-1517	16	3	university	university	PROPN
dpc-1517	16	4	hospital	hospital	NOUN
dpc-1517	16	5	,	,	PUNCT
dpc-1517	16	6	leganés	leganés	PROPN
dpc-1517	16	7	,	,	PUNCT
dpc-1517	16	8	madrid	madrid	PROPN
dpc-1517	16	9	.	.	PUNCT
dpc-1517	17	1	e	e	X
dpc-1517	17	2	-	-	NOUN
dpc-1517	17	3	mail	mail	NOUN
dpc-1517	17	4	:	:	PUNCT
dpc-1517	17	5	martamgml@yahoo.es	martamgml@yahoo.es	NOUN
dpc-1517	17	6	introduction	introduction	NOUN
dpc-1517	17	7	geographic	geographic	ADJ
dpc-1517	17	8	tongue	tongue	NOUN
dpc-1517	17	9	condition	condition	NOUN
dpc-1517	17	10	,	,	PUNCT
dpc-1517	17	11	or	or	CCONJ
dpc-1517	17	12	benign	benign	ADJ
dpc-1517	17	13	migratory	migratory	ADJ
dpc-1517	17	14	glossitis	glossitis	NOUN
dpc-1517	17	15	,	,	PUNCT
dpc-1517	17	16	is	be	AUX
dpc-1517	17	17	a	a	DET
dpc-1517	17	18	self	self	NOUN
dpc-1517	17	19	-	-	PUNCT
dpc-1517	17	20	limited	limit	VERB
dpc-1517	17	21	and	and	CCONJ
dpc-1517	17	22	often	often	ADV
dpc-1517	17	23	recurrent	recurrent	ADJ
dpc-1517	17	24	process	process	NOUN
dpc-1517	17	25	,	,	PUNCT
dpc-1517	17	26	which	which	PRON
dpc-1517	17	27	occurs	occur	VERB
dpc-1517	17	28	in	in	ADP
dpc-1517	17	29	around	around	ADP
dpc-1517	17	30	2.5	2.5	NUM
dpc-1517	17	31	%	%	NOUN
dpc-1517	17	32	.	.	PUNCT
dpc-1517	18	1	of	of	ADP
dpc-1517	18	2	the	the	DET
dpc-1517	18	3	general	general	ADJ
dpc-1517	18	4	population	population	NOUN
dpc-1517	18	5	.	.	PUNCT
dpc-1517	19	1	the	the	DET
dpc-1517	19	2	diagnosis	diagnosis	NOUN
dpc-1517	19	3	is	be	AUX
dpc-1517	19	4	clinical	clinical	ADJ
dpc-1517	19	5	and	and	CCONJ
dpc-1517	19	6	is	be	AUX
dpc-1517	19	7	characterized	characterize	VERB
dpc-1517	19	8	by	by	ADP
dpc-1517	19	9	the	the	DET
dpc-1517	19	10	presence	presence	NOUN
dpc-1517	19	11	of	of	ADP
dpc-1517	19	12	atrophic	atrophic	ADJ
dpc-1517	19	13	areas	area	NOUN
dpc-1517	19	14	located	locate	VERB
dpc-1517	19	15	on	on	ADP
dpc-1517	19	16	the	the	DET
dpc-1517	19	17	back	back	NOUN
dpc-1517	19	18	and	and	CCONJ
dpc-1517	19	19	lateral	lateral	ADJ
dpc-1517	19	20	edges	edge	NOUN
dpc-1517	19	21	of	of	ADP
dpc-1517	19	22	the	the	DET
dpc-1517	19	23	tongue	tongue	NOUN
dpc-1517	19	24	,	,	PUNCT
dpc-1517	19	25	caused	cause	VERB
dpc-1517	19	26	by	by	ADP
dpc-1517	19	27	the	the	DET
dpc-1517	19	28	absence	absence	NOUN
dpc-1517	19	29	of	of	ADP
dpc-1517	19	30	filiform	filiform	NOUN
dpc-1517	19	31	papillae	papillae	NOUN
dpc-1517	19	32	.	.	PUNCT
dpc-1517	20	1	its	its	PRON
dpc-1517	20	2	cause	cause	NOUN
dpc-1517	20	3	is	be	AUX
dpc-1517	20	4	unknown	unknown	ADJ
dpc-1517	20	5	,	,	PUNCT
dpc-1517	20	6	it	it	PRON
dpc-1517	20	7	is	be	AUX
dpc-1517	20	8	associated	associate	VERB
dpc-1517	20	9	with	with	ADP
dpc-1517	20	10	multiple	multiple	ADJ
dpc-1517	20	11	systemic	systemic	ADJ
dpc-1517	20	12	diseases	disease	NOUN
dpc-1517	20	13	and	and	CCONJ
dpc-1517	20	14	occasionally	occasionally	ADV
dpc-1517	20	15	with	with	ADP
dpc-1517	20	16	drug	drug	NOUN
dpc-1517	20	17	use	use	NOUN
dpc-1517	20	18	.	.	PUNCT
dpc-1517	21	1	case	case	NOUN
dpc-1517	21	2	presentation	presentation	NOUN
dpc-1517	21	3	here	here	ADV
dpc-1517	21	4	we	we	PRON
dpc-1517	21	5	present	present	VERB
dpc-1517	21	6	a	a	DET
dpc-1517	21	7	case	case	NOUN
dpc-1517	21	8	of	of	ADP
dpc-1517	21	9	a	a	DET
dpc-1517	21	10	43	43	NUM
dpc-1517	21	11	-	-	PUNCT
dpc-1517	21	12	year	year	NOUN
dpc-1517	21	13	-	-	PUNCT
dpc-1517	21	14	old	old	ADJ
dpc-1517	21	15	patient	patient	NOUN
dpc-1517	21	16	diagnosed	diagnose	VERB
dpc-1517	21	17	with	with	ADP
dpc-1517	21	18	infiltrating	infiltrate	VERB
dpc-1517	21	19	ductal	ductal	ADJ
dpc-1517	21	20	carcinoma	carcinoma	NOUN
dpc-1517	21	21	.	.	PUNCT
dpc-1517	22	1	1	1	NUM
dpc-1517	22	2	year	year	NOUN
dpc-1517	22	3	later	later	ADV
dpc-1517	22	4	,	,	PUNCT
dpc-1517	22	5	he	he	PRON
dpc-1517	22	6	presented	present	VERB
dpc-1517	22	7	tumor	tumor	NOUN
dpc-1517	22	8	recurrence	recurrence	NOUN
dpc-1517	22	9	and	and	CCONJ
dpc-1517	22	10	treatment	treatment	NOUN
dpc-1517	22	11	was	be	AUX
dpc-1517	22	12	started	start	VERB
dpc-1517	22	13	with	with	ADP
dpc-1517	22	14	capecitavin	capecitavin	NOUN
dpc-1517	22	15	(	(	PUNCT
dpc-1517	22	16	1500	1500	NUM
dpc-1517	22	17	mg	mg	PROPN
dpc-1517	22	18	/	/	SYM
dpc-1517	22	19	m2	m2	PROPN
dpc-1517	22	20	for	for	ADP
dpc-1517	22	21	14	14	NUM
dpc-1517	22	22	days	day	NOUN
dpc-1517	22	23	)	)	PUNCT
dpc-1517	22	24	and	and	CCONJ
dpc-1517	22	25	bevacizumab	bevacizumab	NOUN
dpc-1517	22	26	(	(	PUNCT
dpc-1517	22	27	15	15	NUM
dpc-1517	22	28	mg	mg	PROPN
dpc-1517	22	29	/	/	SYM
dpc-1517	22	30	m2	m2	PROPN
dpc-1517	22	31	every	every	DET
dpc-1517	22	32	21	21	NUM
dpc-1517	22	33	days	day	NOUN
dpc-1517	22	34	)	)	PUNCT
dpc-1517	22	35	,	,	PUNCT
dpc-1517	22	36	obtaining	obtain	VERB
dpc-1517	22	37	complete	complete	ADJ
dpc-1517	22	38	remission	remission	NOUN
dpc-1517	22	39	.	.	PUNCT
dpc-1517	23	1	in	in	ADP
dpc-1517	23	2	the	the	DET
dpc-1517	23	3	last	last	ADJ
dpc-1517	23	4	12	12	NUM
dpc-1517	23	5	months	month	NOUN
dpc-1517	23	6	he	he	PRON
dpc-1517	23	7	underwent	undergo	VERB
dpc-1517	23	8	maintenance	maintenance	NOUN
dpc-1517	23	9	therapy	therapy	NOUN
dpc-1517	23	10	with	with	ADP
dpc-1517	23	11	bevacizumab	bevacizumab	NOUN
dpc-1517	23	12	(	(	PUNCT
dpc-1517	23	13	15	15	NUM
dpc-1517	23	14	mg	mg	NOUN
dpc-1517	23	15	/	/	SYM
dpc-1517	23	16	m2/21	m2/21	NOUN
dpc-1517	23	17	days	day	NOUN
dpc-1517	23	18	)	)	PUNCT
dpc-1517	23	19	.	.	PUNCT
dpc-1517	24	1	in	in	ADP
dpc-1517	24	2	the	the	DET
dpc-1517	24	3	last	last	ADJ
dpc-1517	24	4	quarter	quarter	NOUN
dpc-1517	24	5	of	of	ADP
dpc-1517	24	6	the	the	DET
dpc-1517	24	7	last	last	ADJ
dpc-1517	24	8	12	12	NUM
dpc-1517	24	9	months	month	NOUN
dpc-1517	24	10	the	the	DET
dpc-1517	24	11	patient	patient	NOUN
dpc-1517	24	12	reported	report	VERB
dpc-1517	24	13	the	the	DET
dpc-1517	24	14	appearance	appearance	NOUN
dpc-1517	24	15	of	of	ADP
dpc-1517	24	16	migratory	migratory	ADJ
dpc-1517	24	17	lesions	lesion	NOUN
dpc-1517	24	18	located	locate	VERB
dpc-1517	24	19	on	on	ADP
dpc-1517	24	20	the	the	DET
dpc-1517	24	21	back	back	NOUN
dpc-1517	24	22	of	of	ADP
dpc-1517	24	23	the	the	DET
dpc-1517	24	24	tongue	tongue	NOUN
dpc-1517	24	25	,	,	PUNCT
dpc-1517	24	26	which	which	PRON
dpc-1517	24	27	evolved	evolve	VERB
dpc-1517	24	28	in	in	ADP
dpc-1517	24	29	outbreaks	outbreak	NOUN
dpc-1517	24	30	and	and	CCONJ
dpc-1517	24	31	were	be	AUX
dpc-1517	24	32	accompanied	accompany	VERB
dpc-1517	24	33	by	by	ADP
dpc-1517	24	34	pain	pain	NOUN
dpc-1517	24	35	and	and	CCONJ
dpc-1517	24	36	stinging	sting	VERB
dpc-1517	24	37	with	with	ADP
dpc-1517	24	38	the	the	DET
dpc-1517	24	39	ingestion	ingestion	NOUN
dpc-1517	24	40	of	of	ADP
dpc-1517	24	41	certain	certain	ADJ
dpc-1517	24	42	foods	food	NOUN
dpc-1517	24	43	.	.	PUNCT
dpc-1517	25	1	the	the	DET
dpc-1517	25	2	patient	patient	NOUN
dpc-1517	25	3	reported	report	VERB
dpc-1517	25	4	no	no	DET
dpc-1517	25	5	clear	clear	ADJ
dpc-1517	25	6	relationship	relationship	NOUN
dpc-1517	25	7	with	with	ADP
dpc-1517	25	8	the	the	DET
dpc-1517	25	9	administration	administration	NOUN
dpc-1517	25	10	of	of	ADP
dpc-1517	25	11	bevacizumab	bevacizumab	PROPN
dpc-1517	25	12	.	.	PUNCT
dpc-1517	26	1	on	on	ADP
dpc-1517	26	2	the	the	DET
dpc-1517	26	3	first	first	ADJ
dpc-1517	26	4	examination	examination	NOUN
dpc-1517	26	5	,	,	PUNCT
dpc-1517	26	6	several	several	ADJ
dpc-1517	26	7	atrophic	atrophic	ADJ
dpc-1517	26	8	plaques	plaque	NOUN
dpc-1517	26	9	were	be	AUX
dpc-1517	26	10	observed	observe	VERB
dpc-1517	26	11	,	,	PUNCT
dpc-1517	26	12	surrounded	surround	VERB
dpc-1517	26	13	by	by	ADP
dpc-1517	26	14	a	a	DET
dpc-1517	26	15	slightly	slightly	ADV
dpc-1517	26	16	elevated	elevated	ADJ
dpc-1517	26	17	,	,	PUNCT
dpc-1517	26	18	white	white	ADJ
dpc-1517	26	19	,	,	PUNCT
dpc-1517	26	20	keratotic	keratotic	ADJ
dpc-1517	26	21	border	border	NOUN
dpc-1517	26	22	,	,	PUNCT
dpc-1517	26	23	arranged	arrange	VERB
dpc-1517	26	24	in	in	ADP
dpc-1517	26	25	a	a	DET
dpc-1517	26	26	concentric	concentric	ADJ
dpc-1517	26	27	fashion	fashion	NOUN
dpc-1517	26	28	(	(	PUNCT
dpc-1517	26	29	figure	figure	NOUN
dpc-1517	26	30	1	1	NUM
dpc-1517	26	31	)	)	PUNCT
dpc-1517	26	32	.	.	PUNCT
dpc-1517	27	1	following	follow	VERB
dpc-1517	27	2	2	2	NUM
dpc-1517	27	3	follow	follow	VERB
dpc-1517	27	4	-	-	PUNCT
dpc-1517	27	5	up	up	NOUN
dpc-1517	27	6	months	month	NOUN
dpc-1517	27	7	,	,	PUNCT
dpc-1517	27	8	an	an	DET
dpc-1517	27	9	additional	additional	ADJ
dpc-1517	27	10	examination	examination	NOUN
dpc-1517	27	11	was	be	AUX
dpc-1517	27	12	performed	perform	VERB
dpc-1517	27	13	.	.	PUNCT
dpc-1517	28	1	a	a	DET
dpc-1517	28	2	notable	notable	ADJ
dpc-1517	28	3	spontaneous	spontaneous	ADJ
dpc-1517	28	4	improvement	improvement	NOUN
dpc-1517	28	5	of	of	ADP
dpc-1517	28	6	the	the	DET
dpc-1517	28	7	lesions	lesion	NOUN
dpc-1517	28	8	was	be	AUX
dpc-1517	28	9	observed	observe	VERB
dpc-1517	28	10	(	(	PUNCT
dpc-1517	28	11	figure	figure	NOUN
dpc-1517	28	12	2	2	NUM
dpc-1517	28	13	)	)	PUNCT
dpc-1517	28	14	.	.	PUNCT
dpc-1517	29	1	conclusions	conclusion	NOUN
dpc-1517	29	2	the	the	DET
dpc-1517	29	3	association	association	NOUN
dpc-1517	29	4	of	of	ADP
dpc-1517	29	5	the	the	DET
dpc-1517	29	6	geographic	geographic	ADJ
dpc-1517	29	7	tongue	tongue	NOUN
dpc-1517	29	8	condition	condition	NOUN
dpc-1517	29	9	with	with	ADP
dpc-1517	29	10	the	the	DET
dpc-1517	29	11	use	use	NOUN
dpc-1517	29	12	of	of	ADP
dpc-1517	29	13	bevacizumab	bevacizumab	NOUN
dpc-1517	29	14	,	,	PUNCT
dpc-1517	29	15	whose	whose	DET
dpc-1517	29	16	target	target	NOUN
dpc-1517	29	17	is	be	AUX
dpc-1517	29	18	the	the	DET
dpc-1517	29	19	vascular	vascular	ADJ
dpc-1517	29	20	endothelial	endothelial	ADJ
dpc-1517	29	21	growth	growth	NOUN
dpc-1517	29	22	factor	factor	NOUN
dpc-1517	29	23	protein	protein	NOUN
dpc-1517	29	24	a	a	PRON
dpc-1517	29	25	(	(	PUNCT
dpc-1517	29	26	vegf	vegf	NOUN
dpc-1517	29	27	-	-	PUNCT
dpc-1517	29	28	a	a	NOUN
dpc-1517	29	29	)	)	PUNCT
dpc-1517	29	30	,	,	PUNCT
dpc-1517	29	31	has	have	AUX
dpc-1517	29	32	recently	recently	ADV
dpc-1517	29	33	been	be	AUX
dpc-1517	29	34	described	describe	VERB
dpc-1517	29	35	[	[	X
dpc-1517	29	36	1	1	NUM
dpc-1517	29	37	]	]	PUNCT
dpc-1517	29	38	.	.	PUNCT
dpc-1517	30	1	vegf	vegf	PROPN
dpc-1517	30	2	-	-	PUNCT
dpc-1517	30	3	a	a	DET
dpc-1517	30	4	activity	activity	NOUN
dpc-1517	30	5	blockade	blockade	NOUN
dpc-1517	30	6	could	could	AUX
dpc-1517	30	7	impede	impede	VERB
dpc-1517	30	8	the	the	DET
dpc-1517	30	9	normal	normal	ADJ
dpc-1517	30	10	reparative	reparative	ADJ
dpc-1517	30	11	capacity	capacity	NOUN
dpc-1517	30	12	of	of	ADP
dpc-1517	30	13	the	the	DET
dpc-1517	30	14	epithelium	epithelium	NOUN
dpc-1517	30	15	at	at	ADP
dpc-1517	30	16	the	the	DET
dpc-1517	30	17	level	level	NOUN
dpc-1517	30	18	of	of	ADP
dpc-1517	30	19	the	the	DET
dpc-1517	30	20	lingual	lingual	ADJ
dpc-1517	30	21	mucosa	mucosa	NOUN
dpc-1517	30	22	,	,	PUNCT
dpc-1517	30	23	which	which	PRON
dpc-1517	30	24	could	could	AUX
dpc-1517	30	25	explain	explain	VERB
dpc-1517	30	26	the	the	DET
dpc-1517	30	27	development	development	NOUN
dpc-1517	30	28	of	of	ADP
dpc-1517	30	29	these	these	DET
dpc-1517	30	30	lesions	lesion	NOUN
dpc-1517	30	31	.	.	PUNCT
dpc-1517	31	1	the	the	DET
dpc-1517	31	2	increasing	increase	VERB
dpc-1517	31	3	use	use	NOUN
dpc-1517	31	4	of	of	ADP
dpc-1517	31	5	this	this	DET
dpc-1517	31	6	type	type	NOUN
dpc-1517	31	7	of	of	ADP
dpc-1517	31	8	drug	drug	NOUN
dpc-1517	31	9	as	as	ADP
dpc-1517	31	10	a	a	DET
dpc-1517	31	11	treatment	treatment	NOUN
dpc-1517	31	12	for	for	ADP
dpc-1517	31	13	multiple	multiple	ADJ
dpc-1517	31	14	tumors	tumor	NOUN
dpc-1517	31	15	might	might	AUX
dpc-1517	31	16	facilitate	facilitate	VERB
dpc-1517	31	17	the	the	DET
dpc-1517	31	18	appearance	appearance	NOUN
dpc-1517	31	19	of	of	ADP
dpc-1517	31	20	new	new	ADJ
dpc-1517	31	21	cases	case	NOUN
dpc-1517	31	22	of	of	ADP
dpc-1517	31	23	geographic	geographic	ADJ
dpc-1517	31	24	tongue	tongue	NOUN
dpc-1517	31	25	.	.	PUNCT
dpc-1517	32	1	an	an	DET
dpc-1517	32	2	in	in	ADP
dpc-1517	32	3	-	-	PUNCT
dpc-1517	32	4	depth	depth	NOUN
dpc-1517	32	5	knowledge	knowledge	NOUN
dpc-1517	32	6	of	of	ADP
dpc-1517	32	7	the	the	DET
dpc-1517	32	8	recently	recently	ADV
dpc-1517	32	9	described	describe	VERB
dpc-1517	32	10	association	association	NOUN
dpc-1517	32	11	of	of	ADP
dpc-1517	32	12	the	the	DET
dpc-1517	32	13	geographic	geographic	ADJ
dpc-1517	32	14	tongue	tongue	NOUN
dpc-1517	32	15	condition	condition	NOUN
dpc-1517	32	16	following	follow	VERB
dpc-1517	32	17	bevacizumab	bevacizumab	PROPN
dpc-1517	32	18	use	use	NOUN
dpc-1517	32	19	will	will	AUX
dpc-1517	32	20	prevent	prevent	VERB
dpc-1517	32	21	misdiagnosis	misdiagnosis	NOUN
dpc-1517	32	22	and	and	CCONJ
dpc-1517	32	23	unnecessary	unnecessary	ADJ
dpc-1517	32	24	treatment	treatment	NOUN
dpc-1517	32	25	in	in	ADP
dpc-1517	32	26	these	these	DET
dpc-1517	32	27	patients	patient	NOUN
dpc-1517	32	28	,	,	PUNCT
dpc-1517	32	29	who	who	PRON
dpc-1517	32	30	are	be	AUX
dpc-1517	32	31	often	often	ADV
dpc-1517	32	32	immunosuppressed	immunosuppressed	ADJ
dpc-1517	32	33	.	.	PUNCT
dpc-1517	32	34	2	2	NUM
dpc-1517	32	35	letter	letter	NOUN
dpc-1517	32	36	|	|	ADV
dpc-1517	32	37	dermatol	dermatol	ADJ
dpc-1517	32	38	pract	pract	NOUN
dpc-1517	32	39	concept	concept	NOUN
dpc-1517	32	40	.	.	PUNCT
dpc-1517	33	1	2021.11(3	2021.11(3	NUM
dpc-1517	33	2	):	):	PUNCT
dpc-1517	33	3	e2021043	e2021043	NOUN
dpc-1517	33	4	references	reference	NOUN
dpc-1517	33	5	1	1	NUM
dpc-1517	33	6	.	.	PUNCT
dpc-1517	33	7	sundar	sundar	PROPN
dpc-1517	33	8	s	s	PART
dpc-1517	33	9	,	,	PUNCT
dpc-1517	33	10	burge	burge	PROPN
dpc-1517	33	11	f.	f.	PROPN
dpc-1517	33	12	geographical	geographical	PROPN
dpc-1517	33	13	tongue	tongue	NOUN
dpc-1517	33	14	induced	induce	VERB
dpc-1517	33	15	by	by	ADP
dpc-1517	33	16	axitinib	axitinib	NOUN
dpc-1517	33	17	.	.	PUNCT
dpc-1517	33	18	 	 	SPACE
dpc-1517	34	1	bmj	bmj	PROPN
dpc-1517	34	2	case	case	NOUN
dpc-1517	34	3	rep	rep	PROPN
dpc-1517	34	4	.	.	PROPN
dpc-1517	34	5	2015	2015	NUM
dpc-1517	34	6	;	;	PUNCT
dpc-1517	34	7	2015	2015	NUM
dpc-1517	34	8	:	:	PUNCT
dpc-1517	34	9	bcr2015211318	bcr2015211318	NOUN
dpc-1517	34	10	.	.	PUNCT
dpc-1517	35	1	2015	2015	NUM
dpc-1517	35	2	oct	oct	NOUN
dpc-1517	35	3	16	16	NUM
dpc-1517	35	4	.	.	PUNCT
dpc-1517	36	1	doi:10.1136	doi:10.1136	NOUN
dpc-1517	36	2	/	/	SYM
dpc-1517	36	3	bcr-2015	bcr-2015	PROPN
dpc-1517	36	4	-	-	PUNCT
dpc-1517	36	5	211318	211318	NUM
dpc-1517	36	6	.	.	PUNCT
dpc-1517	37	1	pmid:26475876	pmid:26475876	X
dpc-1517	37	2	figure	figure	NOUN
dpc-1517	37	3	1	1	NUM
dpc-1517	37	4	.	.	PUNCT
dpc-1517	38	1	atrophic	atrophic	ADJ
dpc-1517	38	2	plaques	plaque	NOUN
dpc-1517	38	3	surrounded	surround	VERB
dpc-1517	38	4	by	by	ADP
dpc-1517	38	5	a	a	DET
dpc-1517	38	6	keratotic	keratotic	ADJ
dpc-1517	38	7	border	border	NOUN
dpc-1517	38	8	figure	figure	NOUN
dpc-1517	38	9	2	2	NUM
dpc-1517	38	10	.	.	PUNCT
dpc-1517	38	11	improvement	improvement	NOUN
dpc-1517	38	12	of	of	ADP
dpc-1517	38	13	lesions	lesion	NOUN